Share

Mexico participates in Walvax COVID-19 vaccine trials

Media Dec 7, 2021 adn40

Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.

Related Links

CEPI partners with Shanghai Zerun Biotech to develop COVID-19 variant vaccine

Walvax announces the receipt of the purchase order from Morocco for the 13-valent pneumococcal polysaccharide conjugate vaccine

Walvax and RNAcure Announce Safety, Immunogenicity and Efficacy Data from Phase 3b Clinical Study of RQ3013 (SARS-CoV-2 Variants mRNA Vaccine) Published in eClinicalMedicine